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Abstract
Background: Chlamydiae induce persistent infections, which have been associated with a wide range of chronic
diseases in humans and animals. Mixed infections with Chlamydia and porcine epidemic diarrhea virus (PEDV) may
result in generation of persistent chlamydial infections. To test this hypothesis, an in vitro model of dual infection
with cell culture-adapted PEDV and Chlamydia abortus or Chlamydia pecorum in Vero cells was established.
Results: Infected cultures were investigated by immunofluorescence (IF), transmission electron microscopy (TEM)
and re-infection experiments. By IF, Chlamydia-infected cells showed normal inclusions after 39 hpi. Dual infections
with Chlamydia abortus revealed a heterogenous mix of inclusion types including small inclusions consisting of
aberrant bodies (ABs), medium-sized inclusions consisting of ABs and reticulate bodies and normal inclusions. Only
aberrant inclusions were observable in dual infection experiments with Chlamydia pecorum and PEDV. TEM
examinations of mixed infections with Chlamydia abortus and Chlamydia pecorum revealed aberrant chlamydial
inclusions containing reticulate-like, pleomorphic ABs, which were up to 2 μm in diameter. No re-differentiation
into elementary bodies (EBs) was detected. In re-infection experiments, co-infected cells produced fewer EBs than
monoinfected cells.
Conclusions: In the present study we confirm that PEDV co-infection alters the developmental cycle of member
species of the family Chlamydiaceae, in a similar manner to other well-described persistence induction methods.
Interestingly, this effect appears to be partially species-specific as Chlamydia pecorum appears more sensitive to
PEDV co-infection than Chlamydia abortus, as evidenced by TEM and IF observations of a homogenous population
of aberrant inclusions in PEDV - Chlamydia pecorum co-infections.
Background
Chlamydiae are implicated in a wide variety of diseases
in both animals and humans. Although acute infections
in animal chlamydioses are the most commonly
reported, chronic chlamydial infections are also asso-
ciated with a variety of diseases in humans and animals.
These latter infections are characterized by inflamma-
tion and scarring resulting in significant damage of the
host. A causative role in chronic diseases requires that
chlamydiae persist within infected tissue for extended
periods of time. Current theories, based primarily on in
vitro data, suggest that chlamydial persistence, and the
resulting chronic inflammation, is linked to
morphological and metabolic conversion of the actively
replicating and intracellular reticulate body (RB) into an
alternative, non-replicative form known as an aberrant
body (AB) [1]. In vitro, alterations of the normal devel-
opmental cycle of Chlamydia trachomatis and Chlamy-
dia pneumoniae can be induced by Interferon-g (IFN-g),
tumor necrosis factor-a (TNF-a) and penicillin G expo-
sure as well as amino acid or iron deprivation and
monocyte infection [2,3]. To date, in vitro models for
animal pathogens, Chlamydia abortus and Chlamydia
pecorum have not been described although both organ-
isms are associated with chronic disease in koalas and
small ruminants [1].
In pigs, several chlamydial species, including Chlamy-
dia abortus, Chlamydia psittaci, Chlamydia pecorum
and Chlamydia suis, have been implicated in a variety of
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pericarditis, polyserositis, arthritis, abortion and inferti-
lity [4]. In the gastrointestinal tract, chlamydiae appear
to be highly prevalent but only occasionally cause enter-
itis. They have been found in the intestine of diarrheic
and healthy pigs and could be demonstrated in mixed
enteric infections [5-7]. Pospischil and Wood [7] first
described an association between Chlamydiaceae and
lesions in the intestinal tract of pigs and assumed a
synergistic effect in co-existence with Salmonella typhi-
murium. Further, mixed infections with Eimeria scabra,
cryptosporidia, and porcine epidemic diarrhea virus
(PEDV) have been described in the past. PEDV, a mem-
ber of the family Coronaviridae, is a well-known cause
of diarrhea in pigs. After the identification of PEDV in
1978 by Pensaert and Debouck [8], more than a decade
passed before the virus could be adapted for propaga-
tion in cell cultures. Examination of infected Vero cell
cultures by direct immunofluorescence revealed single
cells with granular cytoplasmic fluorescence as well as
formation of syncytia with up to 50-100 nuclei or more.
Typical features of syncytial cells were growth, fusion
and detachment from cell layers after they had reached
a certain size [9]. Biomolecular studies revealed major
genomic differences between cell culture-adapted (ca)-
PEDV and wild type virus [10,11].
Cell culture model of co-infection with ca-PEDV and
Chlamydia has been established recently [12] to investi-
gate the interaction of ca-PEDV and Chlamydiaceae in
mixed infections and to detect possible synergistic or
additive effects of possible significance in clinical enteric
disease in pigs. In that study, abnormally large chlamy-
dial forms were observed in dually infected cell layers by
immunofluorescence suggesting that ca-PEDV co-infec-
tion might alter the chlamydial developmental cycle in a
manner similar to that observed during persistent infec-
tions. To confirm these initial observations, we estab-
lished a cell culture model of mixed infections with
Chlamydia and a cell culture-adapted porcine epidemic
diarrhea virus (ca-PEDV) and hypothesized that this
would result in the generation of persistent chlamydial
forms. This data demonstrates that ca-PEDV co-infec-
tion, indeed, alters the developmental cycle of Chlamy-
dia pecorum and Chlamydia abortus in a similar
manner to other inducers of chlamydial persistence.
Results
Vero cells can be co-infected with Chlamydia and ca-PEDV
Immunofluorescence (IF) labeling was used to investi-
gate the morphologic differences of Chlamydia between
monoinfected and dually infected monolayers using
Chlamydia and ca-PEDV specific antibodies. Control
and mock-infected cells did not stain with either
antibody.
Ca-PEDV monoinfected cells showed brilliant and dis-
tinct, red cytoplasmic fluorescence. Syncytia were char-
acterized by accumulation of nuclei in the center or the
periphery of the multi-nucleated cells and moderate to
bright, fine-granular, cytoplasmic ca-PEDV labeling (Fig-
ure 1b). Syncytia were categorized into small (2-15
nuclei), medium (16-30 nuclei) and large (more than 30
nuclei). In single infection experiments, syncytia at 24 h
post infection were mostly large with fewer medium
sized syncytia observed (data not shown). Numbers of
syncytia in ca-PEDV single and dual infections were
counted on the whole coverslip and mean values were
determined. No difference of viral syncytia numbers for
ca-PEDV monoinfection and dual infection with Chla-
mydia abortus were seen (data not shown). In contrast,
numbers of viral synyctia in dual infections with Chla-
mydia pecorum were diminished compared to the
respective ca-PEDV single infections (Table 1).
IF microscopy of chlamydial single infections revealed
intracytoplasmic, mainly round to ovoid, sharply out-
lined inclusions with brilliant, green fluorescence. Chla-
mydia abortus and Chlamydia pecorum infected cells
had one to five, finely granular (consisting mainly of
EBs) inclusion(s) per cell at 39 h post infection (Figure
Figure 1 Morphology of Chlamydia pecorum mono- and co-
infection with PEDV. a) Vero cells were infected with Chlamydia
pecorum 1 MOI for 39 h, with subsequent PEDV inoculation and
labelled with an anti-Chlamydia antibody (green); b) double infected
monolayer were labelled for ca-PEDV in red, Chlamydia in green
and DNA in blue; c) Chlamydia pecorum mono-infected Vero cells
labelled with an anti-Chlamydia antibody (green) and DNA staining
(blue); d) Inclusion size was measured as described and the
frequency of chlamydial inclusions assembled into sizes of 50 μm
2
area groups depicted. The difference between mono and double
infected monolayers was statistically analyzed using students t-test.
The groups were significantly different with p = 0.0044.
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and had more variable forms in Chlamydia pecorum
than in Chlamydia abortus single infections. Infectivity
was almost 100% and a moderate number of free EBs
could be observed.
Ca-PEDV co-infection alters morphology and size of
chlamydial inclusions
Compared to single infections, the size and shape of
chlamydial inclusions in PEDV co-infections was highly
variable. In Chlamydia abortus co-infection experi-
ments, three types of inclusions were observed: (i) small
inclusions consisting of 1-10 aberrant bodies (ABs), (ii)
medium-sized inclusions consisting of ABs and reticu-
late bodies (RBs), and (iii) large (normal) inclusions con-
sisting of EBs as seen in the single infection experiments
(Figure 2b).
In contrast, dual infections with ca-PEDV and Chla-
mydia pecorum resulted in the exclusive production of
aberrant inclusions containing between 2-50 ABs. Chla-
mydial inclusions in viral syncytia grew even larger than
in non-viral infected Vero cells. Overall, no normal chla-
mydial inclusions were observed (Figure 1a &1b).
Image analysis was used to compare inclusion size in
single chlamydiae-infected Vero cells with the inclusion
size in Vero monolayers that subsequently underwent
ca-PEDV virus infection. To this end, inclusion size was
determined in μm
2 and all inclusions were assembled
into groups covering 50 μm
2 and multiples of this area.
T h ea v e r a g ef r e q u e n c yo fChlamydia pecorum inclu-
sions between 100 μm
2 and 400 μm
2 was significantly
reduced when cells were subsequently infected with ca-
PEDV. In other words, Chlamydia pecorum inclusions
Figure 2 Morphology of Chlamydia abortus mono- and co-
infection with PEDV. a) Vero cells were infected with Chlamydia
abortus 1 MOI for 39 h stained with an anti-Chlamydia antibody
(green). Nuclei of Vero cells are visualized by DAPI stain (blue); b)
Vero cells were infected with Chlamydia abortus with subsequent
PEDV inoculation and stained as with an anti-Chlamydia antibody
and DAPI; c) Frequency of inclusions with various sizes was
calculated and mono and double infected cells were compared
according to the inclusion size. The difference between mono and
double infected monolayers was statistically analyzed using students
t-test. The groups were significantly different with p = 0.0132.
Figure 3 Ultrastructure of chlamydial infection. Vero cells were
infected with Chlamydia abortus (MOI 1) or Chlamydia pecorum
(MOI 1), respectively for 39 h, fixed with glutaraldehyde, and further
processed as described in material and methods. a) Chlamydia
abortus mono infection containing many RBs and a few EBs. b) A
more lobular Chlamydia pecorum mono infection inclusion
containing many RBs, IBs and EBs. c) Chlamydia abortus double
infection with ca-PEDV showing an inclusion of the growing
phenotype on the right aspect of the picture and an inclusion
consisting of RBs and large aberrant bodies in the adjacent cell on
the left aspect of the picture. d) Chlamydia pecorum double
infection with ca-PEDV depicting a small inclusion with aberrant
bodies exclusively.
Table 1 Numbers of syncytia for ca-PEDV monoinfection
compared with dual infection with Chlamydia pecorum
Number of syncytia
a
Experimental group
b Experiment
1
Experiment
2
Experiment
3
Mock 0 0 0
Ca-PEDV 102 23 159
Chlamydia pecorum 000
Chlamydia pecorum/ca-
PEDV
831 6
a Numbers of syncytia for ca-PEDV monoinfection and dual infection with
Chlamydia pecorum were counted on the whole coverslip.
b Vero cells were mock infected (Mock), C. pecorum infected, ca-PEDV infected
(ca-PEDV) and Chlamydia pecorum/ca-PEDV co-infected as described.
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tions than in those infections without the addition of
virus (Figure 1d) as analyzed by t-test (p = 0.0044). The
additional changes observed in the shape of all inclu-
sions growing in virus-infected monolayers indicated the
induction of Chlamydia pecorum persistence, since the
finely dispersed staining reverted to grape-like structures
(Figure 1a &1b).
The changes of chlamydial inclusion size by subse-
quent virus addition to Chlamydia abortus are different
to those we observed in the Chlamydia pecorum dual
infection experiments. The frequency of inclusions
observed between a size range of 0-200 μm
2 was signifi-
cantly (p = 0.0132) reduced under virus infection but
the amount of medium sized and big inclusions 300 -
700 μm
2 was increased (Figure 2c). The morphology of
Chlamydia abortus inclusions was also found to differ
in the population when co-infected with ca-PEDV.
Smaller inclusions were generally observed in aberrant
shapes compared to larger inclusions, which appeared
similar to normal actively growing inclusions showing
finely dispersed staining (Figure 2b). This effect might
b ed u et oa ni n c o m p l e t ei n d u c t i o no fp e r s i s t e n c eo f
Chlamydia abortus when cells were ca-PEDV
coinfected.
Co-infection with ca-PEDV induced ultrastructural
morphological changes in Chlamydia abortus and
Chlamydia pecorum
Persistent forms of Chlamydia trachomatis and Chlamy-
dia pneumoniae are well described by their characteris-
tic electron microscopic appearance [2,13,14]. Thus,
chlamydial ultrastructure in single and co-infected cells
was compared by transmission electron microscopy
(TEM).
At 24 h after viral infection, viral-induced syncytia
containing vacuoles filled with viral particles were pre-
sent in ca-PEDV-monoinfected and dual infections. The
viral particles showed the typical Coronavirus morphol-
ogy with a diameter between 50 to 130 nm (data not
shown). At 39 h after chlamydial infection, large intracy-
toplasmic chlamydial inclusions in single infected cells
could be observed in Vero cells infected with Chlamydia
abortus or Chlamydia pecorum. The inclusions observed
contained variable numbers of morphologically normal
RBs and EBs and were generally located near the host
cell nucleus, often surrounded by mitochondria
(Figure 3a and 3b).
TEM examinations of mixed infections (ca-PEDV and
Chlamydia abortus or Chlamydia pecorum) revealed
aberrant chlamydial inclusions containing fewer bacteria
than typical inclusions and were located in viral syncytia
or single cells without viral infection. Aberrant inclu-
sions consisted of reticulate-like, pleomorphic, aberrant
bodies (ABs), which were in general larger in diameter
(up to 2 μm) than typical reticulate bodies (RBs), with a
sparse densitometric appearance and no re-differentia-
tion into elementary bodies (EBs). As already observed
in IF investigations, three types of inclusions were pre-
sent in dual infections with ca-PEDV and Chlamydia
abortus (Figure 3c), whereas dual infections with ca-
PEDV and Chlamydia pecorum resulted in the exclusive
production of aberrant inclusions consisting of 2-50 ABs
(Figure 3d).
Neither chlamydial inclusions nor ca-PEDV virions
were visible in mock-infected cells.
ca-PEDV superinfection inhibition of infectious chlamydial
EBs is chlamydial strain-specific
Previous studies have demonstrated that chlamydial per-
sistent forms are non-infectious [2]. Reduced number or
even a lack of EBs in co-infected cells in TEM suggested
arrested chlamydial developmental cycle with halted
maturation from RB to EB. To ascertain the effect of ca-
PEDV inhibition of chlamydial EB production, the yield
of infective chlamydial progeny was determined after 40
h of re-infection in three independent experiments for
Chlamydia abortus (Figure 4a) and for Chlamydia
pecorum (Figure 4b). Neither mock nor ca-PEDV mono-
infected cells produced detectable infectious EBs,
whereas Chlamydia abortus and Chlamydia pecorum
single infections cells produced abundant EBs. Co-
infected cells produced fewer infectious EBs than non-
viral infected cells, demonstrating that production of
infectious chlamydial progeny was essentially diminished
by ca-PEDV-co-infection. Eradication of infectious EB
production was almost complete in Chlamydia pecorum
double infection, analyzed by reinfection experiments
and found to be statistically different as analyzed by t-
test (p = 0.0145) (Figure 4b). In Chlamydia abortus
reinfection analysis, several EBs could still be observed
in spite of the co-infection with ca-PEDV (Figure 4a).
Statistical analysis by t-test revealed no statistical
Figure 4 Reinfection analysis of three independent
experiments. a) number of inclusions of Chlamydia abortus
inclusions after reinfection from mono and double infection. b)
number of inclusions of Chlamydia pecorum after reinfection from
mono and double infection.
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iation in the data.
This data is consistent with the observations from our
IF and ultrastructural analysis.
Chlamydial co-infection does alter ca-PEDV infection
depending on the chlamydial species but does not alter
viral ultrastructure
To determine whether chlamydial pre-infection altered
subsequent viral infection, numbers of syncytia and ca-
PEDV-infected cells from single and co-infected mono-
layers of three unrelated experiments were counted.
Mock-infected and Chlamydia only infected cells pro-
duced no virions. The difference between virus-infected
cells and co-infection with Chlamydia abortus was mini-
mal. The number of syncytia detected were within the
same range (data not shown) indicating that chlamydial
co-infection with Chlamydia abortus does not alter ca-
PEDV infection or the development of syncytia. In con-
trast, numbers of syncytia in co-infection with Chlamy-
dia pecorum were reduced compared to single ca-PEDV
infection (Table 1).
Overall numbers of single viral infected cells were low
in both single and co-infection experiments, and no sig-
nificant difference between the two chlamydial species
was obvious (data not shown).
Viral morphology was also studied by TEM. In ca-
PEDV single and co-infected cells, viral particles were
unaltered indicating that chlamydial co-infection did not
induce any changes in viral ultrastructural morphology.
Discussion
While a previous study [12] primarily investigated the
interaction of ca-PEDV and Chlamydiaceae in mixed
infections to detect possible synergistic or additive
effects of these two pathogens, questions remained
about whether viral infection could potentially induce
the persistent chlamydial phenotype. Enlarged chlamy-
dial inclusions were described in that study in the ca-
PEDV co-infection model with Chlamydia abortus and
Chlamydia pecorum but no further ultrastructural analy-
sis has been subsequently performed. In this study, in
vitro models of Chlamydia abortus and Chlamydia
pecorum persistence were established using co-infection
with ca-PEDV. Several experimental methods were used
to demonstrate the characteristic features of chlamydial
persistence, including altered ultrastructural morphology
and decreased production of infectious EBs. Our results
demonstrated that ca-PEDV-co-infection alters the chla-
mydial developmental cycle similarly to other inducers
of chlamydial persistence. A similar co-infection model
has been recently described by Deka et al. (2006) [15].
In that study, it was shown that Chlamydia trachomatis
enters a viable but non-cultivable, persistent state with
herpes simplex virus type 2 (HSV-2) co-infected host
cells. In contrast, a similar study investigating a co-
infection model with Chlamydia trachomatis and genital
mycoplasmas, Mycoplasma genitalium and Mycoplasma
hominis, did not change the morphology of chlamydial
RBs, indicating that co-infection of these two microor-
ganisms is likely to be independent and not related to
the onset of chlamydial persistence [16]. In the study by
Deka et al. (2006) [15], HeLa monolayers were first
infected with Chlamydia trachomatis and 24 h later
with HSV-2. In our study, the optimal experimental pro-
tocol for co-infection procedure was developed, based
on our own earlier study [12], and optimization experi-
ments performed as a part of the current study (data
not shown). To this end, Vero monolayers were first
infected with Chlamydia and later with ca-PEDV, thus
the suspected inducer of persistence would be intro-
duced after chlamydial infection and differentiation into
RBs. Simultaneous infection of Chlamydia and ca-PEDV
has been performed earlier [12], but did not result in
persistent infection in our preliminary experiments (data
not shown) and was not considered further as interfer-
ence of chlamydial infection and concurrent viral uptake
could have influenced the results. Viral infection and
subsequent development of syncytia was not affected by
co-infection with Chlamydia abortus as demonstrated
by unaltered numbers of syncytia observed in the co-
infection experiments. In contrast, viral syncytia forma-
tion was dramatically decreased in Vero cells double
infected with ca-PEDV and Chlamydia pecorum.I f
Chlamydia pecorum infection might induce a down reg-
ulation of the host PEDV receptor needed for syncytium
formation at 14-15 hours post-chlamydial infection, this
could produce a reduction in syncytium formation with-
out reducing viral entry or replication - the possible per-
sistence inducer mechanism.
Interestingly, chlamydial persistence was more promi-
nent in co-infection with Chlamydia pecorum than with
Chlamydia abortus, indicating possible species-specific
differences. Limited reports are available for in vitro
models of chlamydial persistence from non-Chlamydia
trachomatis and Chlamydia pneumoniae strains. Kalten-
boeck and Storz (1992) [17] suggested that strain 1710S
of Chlamydia pecorum is highly nutrient dependent and
this could elicit aberrant forms. Indeed, aberrant forms
of this strain were significantly present in our study.
Previously, only limited data have been published on
persistent infection of L cells with an ovine abortion
strain of Chlamydia psittaci (current classification:
Chlamydia abortus) [18]. It should be noted, that in the
latter study, chlamydial persistence was not demon-
strated using the characteristic features now associated
with the morphology of persistent chlamydial infections.
Detailed description of electron microscopic
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ogy of Chlamydia psittaci Cal10 in L cells showing
aberrant chlamydial stages were published by Matsu-
moto and Manire [13].
The different occurence of persistent forms in co-
infection with Chlamydia abortus and Chlamydia
pecorum, respectively, has not been described before.
Differences between persistence behaviour are already
known (reviewed by Hogan et al., 2004) [1] not only
between different chlamydial species but also between
different serovars and strains of Chlamydia pneumoniae
and Chlamydia trachomatis, respectively. The fact that
Chlamydia pecorum strain 1710S is an original swine
isolate whereas Chlamydia abortus strain S26/3 origi-
nates from a sheep abortion and, thus, from another
animal species could have an impact but needs further
investigation.
The mechanism by which ca-PEDV interferes with
chlamydial developmental cycle and chlamydial persis-
tence is still unclear. It is known that Vero cells, a mon-
key kidney epithelial cell line, is deficient for Interferon
production [19]; thus, this cytokine group well known to
be capable of inducing in vitro persistence in Chlamydia
pneumoniae [1], cannot be relevant for our co-infection
persistence model. Co-infection experiments with ca-
PEDV are best performed with Vero cells, as they have
been shown to be permissive for viral replication in con-
trast to other cell lines such as PD5, PK 15, and HRT18
cell lines [9]. Specific measurements of primate cyto-
kines in our co-infection model are planned in the
future to elucidate the mechanism leading to chlamydial
persistence. The Herpes simplex virus (HSV) co-induced
Chlamydia trachomatis persistence model [15] has been
recently been shown not to be mediated by any known
persistence inducer or anti-chlamydial pathway recently
[20,21]. Instead, it was hypothesized by the authors that
HSV-2 attachment and/or entry into the host cell is suf-
ficient for stimulating chlamydial persistence, suggesting
a potential novel host signaling pathway could be
responsible for inducing chlamydial persistence. A very
recent publication by the same group showed that HSV
replication is not necessary for persistence induction
and that chlamydial activity could be recovered after co-
infection with UV-inactivated HSV-2. Finally, it was
concluded that the interaction of HSV glycoprotein D
with the host cell surface is crucial to trigger chlamydial
persistence [22].
Female genital tract infection often has a complex
etiology, where Chlamydia trachomatis is present
together with one or more genital agents. Epidemiolo-
gical and clinical studies have shown that double infec-
tion with HSV-2 and Chlamydia trachomatis occurs in
vivo;t h u s ,t h ein vitro model described by Deka et al.
(2006) [15] represents a realistic situation in human
medicine. Similarities exist to the in vitro model estab-
lished in this study as simultaneous intestinal infection
with different pathogens is possible in swine in vivo.A
recent study [23] documented the occurrence of aber-
rant chlamydial bodies in vivo in intestinal tissues of
pigs. In this study, aberrant bodies of Chlamydia suis
were demonstrated and characterized in the gut of pigs
experimentally infected with Salmonella typhimurium
by transmission electron microscopy. It was concluded
by Pospischil et al. [23] that aberrant bodies occur in
vivo in pigs and that the gnotobiotic pig model might
be suitable for the study of chlamydial persistence in
vivo.
Available intestinal tissues from experimentally
infected gnotobiotic piglets (single infection and co-
infection with Chlamydia and ca-PEDV, respectively)
will be investigated in the future with the aim of further
characterization of ABs in vivo. Although chronic chla-
mydial diseases in animals are of economic impact, the
pig model may also reveal the important link between
persistence in vitro and in vivo and, thus, help to eluci-
date mechanisms of chronic human chlamydial infec-
tions in the future.
Conclusions
T h ep r e s e n ts t u d yr e p o r t san e wp e r s i s t e n c em o d e lo f
Chlamydia in co-infection with porcine epidemic diar-
rhea virus (PEDV). PEDV-co-infection altered the chla-
mydial developmental cycle similarly to other known
inducers of chlamydial persistence. This new animal
model could provide the important link between persis-
tence in vitro and in vivo and, thus, would help to eluci-
date mechanisms of chronic human chlamydial
infections in the future.
Methods
Media and cells
Growth medium (GM) for normal cell propagation was
Minimal Essential Medium (MEM) with Earle’ss a l t s ,2 5
mM HEPES, without L-Glutamine (GIBCO, Invitrogen,
Carlsbad, CA) and supplemented with 10% fetal calf
serum (FCS) (BioConcept, Allschwil, Switzerland), 4
mM GlutaMAX-I (200 mM, GIBCO) and 0.2 mg/ml
gentamycin (50 mg/ml, GIBCO).
GM without gentamycin was used for the propagation
of cells for infection experiments. Infection medium was
prepared as GM but without gentamycin and FCS, and
was used for the infection and for the 24 h incubation
period after the infection with ca-PEDV, respectively.
Incubation medium was prepared as GM without genta-
mycin, freshly supplemented with 1 μg/ml cyclohexi-
mide (Sigma, Buchs SG, Switzerland), and used after an
infection for estimation of the chlamydial titer (IFU
determination).
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1587 American Type Culture Collection) were seeded
on round plastic coverslips (13 mm diameter, Bibby
Sterilin, Stone, UK) and cultured in GM without genta-
mycin at 37°C until they reached confluence. Before
inoculation, the cells were washed once with phosphate
buffered saline (PBS).
Chlamydial strains
Two different chlamydial strains of Chlamydiaceae were
used in this study: Chlamydia abortus S26/3 (ovine
abortion strain, kindly donated by Dr. G.E. Jones, More-
dun Research Institute, Edinburgh, GB) and Chlamydia
pecorum 1710S (intestinal swine isolate, kindly provided
by Prof. J. Storz, Baton Rouge, Louisiana, LA, USA). For
initial culturing, chlamydial strains were cultured in
embryonated chicken eggs, and yolk sac material was
harvested, diluted 1:2 in sucrose-phosphate-glutamate
(SPG) medium and stored at -80°C. Yolk sac-derived
chlamydiae were then propagated in HEp-2 cell (ATCC
CCL-23) monolayers and elementary bodies (EBs) were
harvested and purified by disruption of HEp-2 cell
monolayers with a cell scraper, sonication and centrifu-
gation over a renografin density gradient as described
elsewhere [24]. EB suspensions were stored in sucrose-
phosphate-glutamic acid buffer at -80°C, after which
viable titers were established using standard methods.
MOI of 1 was used for chlamydial monoinfection and
mixed infection, respectively.
PEDV
Ca-PEDV strain CV777 (kindly provided by Prof. Dr. M.
Ackermann, Institute of Virology, University of Zurich)
was propagated as previously described [9]. The virus
(10
5,5 TCID50/ml) was used undiluted (1 ml 10
5,5
TCID50/ml).
Co-infection experimental design
Vero cells, an African green monkey kidney cell line
(ATCC CRL 1587), were used for all infection experi-
ments. They were propagated in GM without gentamy-
c i na t3 7 ° Ci na na t m o s p h e r eo f5 %C O 2. Vero cells
were divided into four groups: for mock infection, chla-
mydial infection, ca-PEDV infection, and both Chlamy-
dia and ca-PEDV double infection. Host cells were
infected with a MOI of 1 for Chlamydia and an infec-
t i v ed o s eo f1×1 0
5,5 TCID50/ml for ca-PEDV, respec-
tively. For ca-PEDV monoinfections and negative
controls, infection medium was used.
All co-infection experiments were done three times and
monoinfections with Chlamydia and ca-PEDV were per-
formed simultaneously. The optimal experimental proto-
col (adding the virus several hours after chlamydial
infection) for co-infection procedure was developed before
(data not shown).
For dual infections, cell monolayers were first infected
with Chlamydia at a MOI of 1. All coverslips were cen-
trifuged at 1000 × g for 1 h at 25°C. Timepoint 0 (T0)
was defined after centrifugation and supernatant was
replaced subsequently by incubation medium. Infected
monolayers were then incubated for 14 h at 37°C (T0 -
T14). All cell layers for dual infections or ca-PEDV
monoinfection were exposed to a ca-PEDV suspension
(1 × 10
5,5 TCID50), the samples were centrifuged again
for 1000 × g for 1 h at 25°C and incubated for 24 h at
37°C. After this incubation period, all monolayers were
fixed and further investigated by indirect immunofluor-
escence and transmission electron microscopy. Re-infec-
tion experiments were performed to compare the
production of infectious chlamydial elementary bodies
(EBs) between monoinfections and mixed infections.
Indirect Immunofluorescence
For indirect immunofluorescence analyses, infected cells
were fixed in absolute methanol (-20°C) for 10 min. and
IF labeling of cell cultures was performed immediately
after fixation. For viral antigen detection, a mouse
monoclonal antibody against the M protein of PEDV
(mcAb 204, kindly provided by Prof. Dr. M. Ackermann,
Institute of Virology, University of Zurich), diluted 1:4
in PBS supplemented with BSA, and an Alexa Fluor
594-conjugated secondary antibody (goat anti-mouse,
1:500, Molecular Probes, Eugene, USA) were used. Chla-
mydial inclusions were labeled with a Chlamydiaceae
family-specific mouse monoclonal antibody directed
against the chlamydial lipopolysaccharide (mLPS; Clone
ACI-P, Progen, Heidelberg, Germany) and a secondary
Alexa Fluor 488-conjugated secondary antibody (goat
anti-mouse, 1:500, Molecular Probes). DNA was labeled
with 1 μg/ml 4’,6 - D i a m i d i n - 2 ’-phenylindoldihydro-
chlorid (DAPI, Molecular Probes). All staining proce-
dures were conducted at room temperature. Antibody
incubations were carried out for 1 h (primary antibo-
dies) or 45 min (secondary antibodies), respectively,
with three washes of PBS following fixation, between
and after applications of the different antibodies. Dually
infected cell layers were stained using sequential double
immunofluorescence labeling. Uninfected Vero cells
were used as a negative control. Coverslips were
mounted with Immumount (Shandon, Pittsburgh, USA)
on glass slides and investigated using a Leica fluores-
cence microscope.
Transmission electron microscopy
Coverslips from all experimental conditions were fixed
in 2.5% glutaraldehyde (Electron Microscopy Sciences,
Borel et al. BMC Microbiology 2010, 10:201
http://www.biomedcentral.com/1471-2180/10/201
Page 7 of 9Ft. Washington, USA) for 1-2 h, and processed by rou-
tine methods for embedding in epoxy resin (Fluka).
Appropriate areas for ultrastructural investigation were
selected using semithin sections (1 μm) stained with
toluidine blue (Fluka, Buchs SG, Switzerland). Ultrathin
sections (80 nm) were mounted on gold grids (Merck
Eurolab AG, Dietlikon, Switzerland), contrasted with
uranyl acetate dihydrate (Fluka) and lead citrate (lead
nitrate and tri-natrium dihydrate; Merck Eurolab AG)
and investigated in a Philips CM10 electron microscope.
Chlamydial titration by subpassage
At 39 h after chlamydial infection, monolayers were
scraped into 1 ml of cold infection medium, pelleted
and resuspended in 1 ml of fresh medium. Infected host
cells were lysed by sonication and centrifuged (500 g for
5 min) to remove pellet cell debris. Supernatants were
centrifuged once (4,000 g for 60 min). Final EB pellets
were resuspended in 200 μl of SPG and used to infect
Vero cells plated on glass coverslips in duplicate in dilu-
tion series. All coverslips were centrifuged at 1000 × g
for 1 h at 25°C. After centrifugation, the Vero cells were
refed with medium containing 1 μg/ml cycloheximide
and subsequently incubated for 40 h at 37°C. Fixation
and staining of Chlamydia, ca-PEDV and DNA was per-
formed as described above. The number of inclusions in
20 random microscopic fields per sample was deter-
mined using a Leica fluorescence microscope at a mag-
nification of 200 ×. Duplicate coverslips were counted
and the counts were averaged. The number of inclu-
sion-forming units (IFU) in the indiluted inoculum was
then calculated and expressed as IFU per 10
6 cells as
described by Deka et al., 2006 [15].
Imaging and statistical analyses
From duplicate samples of three independent experiments
uniform random sampled images were acquired using a
widefield microscope (Leica LX, Leica Microsystems Man-
nheim, Germany). Cells and inclusions were automatically
detected according to size, shape and intensity and
counted using Imaris (Bitplane AG, Zürich Switzerland).
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